{
    "2020-07-27": [
        [
            {
                "time": "",
                "original_text": "最新排行！17家药企上榜，1家亏损9.278亿！",
                "features": {
                    "keywords": [
                        "药企",
                        "亏损",
                        "排行"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-08-06",
                "original_text": "中证指数公司：8月6日发布中证兴业证券ESG盈利100指数",
                "features": {
                    "keywords": [
                        "中证指数",
                        "ESG",
                        "盈利100指数"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "证券",
                        "ESG"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "《财富》中国500强出炉医疗领域17家医药企业上榜",
                "features": {
                    "keywords": [
                        "财富",
                        "中国500强",
                        "医药企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公募基金产品研究系列之四十-新华沪深300增强：基于量化策略的指数增强产品",
                "features": {
                    "keywords": [
                        "公募基金",
                        "新华沪深300增强",
                        "量化策略",
                        "指数增强"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "指数基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}